Belite Bio, Inc (BLTE)
NASDAQ: BLTE · USD
$153
-2.92 (-1.9%)· Recorded snapshot
Coverage state: Market snapshot only — no published research
Market snapshot recorded 2026-07-27 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.
On-demand research
Generate the first BLTE analysis
Start the full research workflow when this ticker is ready in our data system.
| Market cap | 6B | |
|---|---|---|
| Net income (ttm) | -90.3M | |
| EPS (ttm) | -$2.54 | |
| Shares out | 39.3M | |
| Volume | 172,383 | |
| Beta | -1.23 | |
| Price target | $211 | +37.3% |
Market data
Price
Recent price action with selectable time range.
Financial snapshot
- Net income (ttm)
- -90.3M
- EPS (ttm)
- -$2.54
- Market cap
- 6B
Fair-value bridge
- Current price
- $153
Analyst consensus
Recommendation
Strong Buy
Price target
$211
+37.3%
In the news
Latest news · BLTE
Recent company headlines from major financial publishers.
Valuation
- Market cap
- 6B
- P/B
- 7.6x
Profitability
- ROE
- -18.9%
- ROA
- -13.0%
- ROIC
- -13.3%
Balance sheet
- Current ratio
- 33.71
Trading
- Beta
- -1.23
- Volume
- 172,383
- Dividend yield
- 0.0%